203 related articles for article (PubMed ID: 27869314)
1. Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis.
Kilbey A; Terry A; Wotton S; Borland G; Zhang Q; Mackay N; McDonald A; Bell M; Wakelam MJ; Cameron ER; Neil JC
J Cell Biochem; 2017 Jun; 118(6):1432-1441. PubMed ID: 27869314
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Runx1-Myc axis in p53-deficient thymic lymphoma.
Date Y; Taniuchi I; Ito K
Gene; 2022 Apr; 819():146234. PubMed ID: 35114276
[TBL] [Abstract][Full Text] [Related]
3. Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model.
Borland G; Kilbey A; Hay J; Gilroy K; Terry A; Mackay N; Bell M; McDonald A; Mills K; Cameron E; Neil JC
Oncotarget; 2016 Apr; 7(17):22973-87. PubMed ID: 27056890
[TBL] [Abstract][Full Text] [Related]
4. Runx regulation of sphingolipid metabolism and survival signaling.
Kilbey A; Terry A; Jenkins A; Borland G; Zhang Q; Wakelam MJ; Cameron ER; Neil JC
Cancer Res; 2010 Jul; 70(14):5860-9. PubMed ID: 20587518
[TBL] [Abstract][Full Text] [Related]
5. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
[TBL] [Abstract][Full Text] [Related]
7. Runx1 promotes B-cell survival and lymphoma development.
Blyth K; Slater N; Hanlon L; Bell M; Mackay N; Stewart M; Neil JC; Cameron ER
Blood Cells Mol Dis; 2009; 43(1):12-9. PubMed ID: 19269865
[TBL] [Abstract][Full Text] [Related]
8. RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.
Anderson G; Mackay N; Gilroy K; Hay J; Borland G; McDonald A; Bell M; Hassanudin SA; Cameron E; Neil JC; Kilbey A
J Cell Biochem; 2018 Mar; 119(3):2750-2762. PubMed ID: 29052866
[TBL] [Abstract][Full Text] [Related]
9. RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53.
Wotton SF; Blyth K; Kilbey A; Jenkins A; Terry A; Bernardin-Fried F; Friedman AD; Baxter EW; Neil JC; Cameron ER
Oncogene; 2004 Jul; 23(32):5476-86. PubMed ID: 15133495
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of core binding factorβ alters sphingolipid metabolism.
Greer AH; Yong T; Fennell K; Moustafa YW; Fowler M; Galiano F; Ng SW; Berkowitz RS; Cardelli J; Meyers S; Davis JN
J Cell Physiol; 2013 Dec; 228(12):2350-64. PubMed ID: 23813439
[TBL] [Abstract][Full Text] [Related]
11. The Runx genes: lineage-specific oncogenes and tumor suppressors.
Cameron ER; Neil JC
Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187
[TBL] [Abstract][Full Text] [Related]
12. Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.
Hay J; Gilroy K; Huser C; Kilbey A; Mcdonald A; MacCallum A; Holroyd A; Cameron E; Neil JC
J Cell Biochem; 2019 Oct; 120(10):18332-18345. PubMed ID: 31257681
[TBL] [Abstract][Full Text] [Related]
13. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.
van Bragt MP; Hu X; Xie Y; Li Z
Elife; 2014 Nov; 3():e03881. PubMed ID: 25415051
[TBL] [Abstract][Full Text] [Related]
14. Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival.
Wotton S; Terry A; Kilbey A; Jenkins A; Herzyk P; Cameron E; Neil JC
Oncogene; 2008 Oct; 27(44):5856-66. PubMed ID: 18560354
[TBL] [Abstract][Full Text] [Related]
15. Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.
Loh KC; Baldwin D; Saba JD
Anticancer Agents Med Chem; 2011 Nov; 11(9):782-93. PubMed ID: 21707493
[TBL] [Abstract][Full Text] [Related]
16. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity.
Aho TL; Sandholm J; Peltola KJ; Ito Y; Koskinen PJ
BMC Cell Biol; 2006 May; 7():21. PubMed ID: 16684349
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
18. Runx transcription factors repress human and murine c-Myc expression in a DNA-binding and C-terminally dependent manner.
Jacobs PT; Cao L; Samon JB; Kane CA; Hedblom EE; Bowcock A; Telfer JC
PLoS One; 2013; 8(7):e69083. PubMed ID: 23874874
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
Gao XY; Li L; Wang XH; Wen XZ; Ji K; Ye L; Cai J; Jiang WG; Ji JF
Oncol Rep; 2015 Oct; 34(4):1977-87. PubMed ID: 26239167
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.
Le Stunff H; Galve-Roperh I; Peterson C; Milstien S; Spiegel S
J Cell Biol; 2002 Sep; 158(6):1039-49. PubMed ID: 12235122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
